In addition, CPC specializes in the production of genericpeptides on an industrial scale, following the CGMP's (CurrentGood Manufacturing Practices). Our expertise allows us tomanufacture a range of high-quality generic peptides at acommercial scale. With stringent quality control measures inplace, we ensure consistent and reliable production of genericpeptides that meet regulatory standards. Our GenericAPI Portfolio:
|
Disease Area |
API |
Indication |
DMF Status |
|
Tumour |
Leuprorelin Acetate |
Prostate & Breast Cancer; Endometriosis; Uterine Leiomyomata; Precocious Puberty |
MFDS: 20200625-210-J-661 NMPA: Y20190007496(A) TFDA: 110DMF050097 |
|
Triptorelin Acetate |
Prostate & Breast Cancer; Endometriosis; Uterine Leiomyomata; Assisted Reproduction |
NMPA: Y20170001090(A) |
|
|
Goserelin Acetate |
Suppress production of the sex hormones |
NMPA: Y20230000413 |
|
|
Triptorelin Pamoate |
Endometriosis; Uterine Fibroids; Premature Puberty; Prostate Cancer; ART. |
NMPA：2024 Q2 |
|
|
Procreation |
Cetrorelix Acetate |
In Vitro Fertilization (IVF) |
NMPA: Y20190001147(A) |
|
Diabetes |
Exenatide Acetate |
Exenatide is an injectable diabetes medicine that helps control blood sugar levels. This medication helps pancreas produce insulin more efficiently |
NMPA: 2015/12 NMPA: Y20170001378 |
|
Semaglutide |
Type ll diabetes |
DMF： 2024 Q1 NMPA： 2024 Q1 |
|
|
Tirzepatide |
Type ll diabetes |
Early R&D |
|
|
Gastrointestinal |
Terlipressin Acetate |
An analogue of vasopressin, prescribed for bleeding esophageal varices, septic shock, hepatorenal syndrome and in management of low blood pressure |
NMPA:Y20200000281(A) CEP : 2020-111 ASMF: The Nethelands (03883) ASMF: Germany (4388) EDQM: R0-CEP 2020-111 |
|
Linaclotide |
lrritable Bowel Syndrome with Constipation (IBS-C): Chronic Idiopathic Constipation (CIC) |
NMPA：Y20210000906 |
|
|
Teduglutide |
A prescription medicine for adults with Short Bowel Syndrome who need additional nutrition or fluids fromIV feeding |
DMF：2024 Q4 |
|
|
Immunology |
Difelikefalin |
Treatment of moderate-to-severe pruritus associated with chronic kidney disease(CKD-aP; uremic pruritus) in adults undergoing hemodialysis |
NMPA：2025 Q1 |
For moreinformation about generic api viewand chinese peptide, please feel free tocontact us!
